MIM
SYNH

MetLife Investment Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

MetLife Investment Management’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-62,110
Closed -$2.62M – 3006
2023
Q2 		$2.62M Sell
62,110
-1,695
-3% -$68.5K 0.02% 816
2023
Q1 		$2.27M Sell
63,805
-1,687
-3% -$61.2K 0.02% 868
2022
Q4 		$2.4M Sell
65,492
-1,171
-2% -$46.3K 0.02% 827
2022
Q3 		$3.14M Sell
66,663
-774
-1% -$50K 0.03% 665
2022
Q2 		$4.83M Sell
67,437
-170
-0.3% -$12.4K 0.04% 437
2022
Q1 		$5.47M Buy
67,607
+17,357
+35% +$1.47M 0.04% 468
2021
Q4 		$5.16M Buy
50,250
+536
+1% +$51.5K 0.04% 383
2021
Q3 		$4.35M Sell
49,714
-883
-2% -$79.9K 0.04% 443
2021
Q2 		$4.53M Buy
50,597
+7,902
+19% +$668K 0.04% 437
2021
Q1 		$3.24M Buy
42,695
+1,152
+3% +$86.8K 0.03% 626
2020
Q4 		$2.83M Buy
41,543
+1,540
+4% +$96K 0.03% 649
2020
Q3 		$2.13M Buy
40,003
+2,887
+8% +$172K 0.02% 694
2020
Q2 		$2.16M Sell
37,116
-25,156
-40% -$1.35M 0.02% 679
2020
Q1 		$2.45M Hold
62,272
– – 0.03% 526
2019
Q4 		$3.7M Sell
62,272
-365
-0.6% -$19.6K 0.04% 512
2019
Q3 		$3.33M Sell
62,637
-1,861
-3% -$95.5K 0.04% 545
2019
Q2 		$3.3M Sell
64,498
-775
-1% -$36.1K 0.04% 563
2019
Q1 		$3.38M Sell
65,273
-11
-0% -$533 0.04% 551
2018
Q4 		$2.57M Sell
65,284
-36
-0.1% -$1.67K 0.03% 638
2018
Q3 		$3.37M Buy
+65,320
New +$3.2M 0.03% 592
2018
Q2 		– Sell
-60,685
Closed -$2.15M – 2233
2018
Q1 		$2.15M Buy
+60,685
New +$2.38M 0.03% 756

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

MetLife Investment Management's SYNH Position: Q3 2023 in Review

MetLife Investment Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 62,110 shares — an estimated $2.62M sold.

MetLife Investment Management first reported a position in SYNH in Q1 2018 and held it in 21 quarters. The position peaked at $5.47M in Q1 2022. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • MetLife Investment Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • MetLife Investment Management sold 62,110 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $2.62M.
  • MetLife Investment Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2018 and held it in 21 quarters.
  • MetLife Investment Management's Syneos Health, Inc. Class A Common Stock position peaked at $5.47M in Q1 2022.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on MetLife Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.